Item 2.02. Results of Operations and Financial Condition. On August 11, 2026, Harvard Bioscience, Inc. (the “Company”) issued a press release announcing financial results for the three and six months ended June 30, 2026, and the details of a related conference call to be held at 8:00 AM ET on August 11, 2026. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.…
Filed Aug 11, 2026Accepted Aug 11, 2026, 7:00 AM EDTCIK 1123494Accession 0001171843-26-005405
Select an item to read the extracted section. The as-filed document remains the primary evidence.
Item 2.02Item 2.02 - Results of Operations
Item 2.02. Results of Operations and Financial Condition.
On August 11, 2026, Harvard Bioscience, Inc. (the “Company”)
issued a press release announcing financial results for the three and six months ended June 30, 2026, and the details of a related conference
call to be held at 8:00 AM ET on August 11, 2026. The press release is furnished as Exhibit 99.1 and incorporated herein by reference.
The information in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 attached
hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange
Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under
the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.